Our company is on a mission to enrich women’s lives through digital innovation. Currently, we are developing a digital medical device (SaMD) aimed at preventing premature births during pregnancy. This product leverages AI technology to visualize pregnancy conditions that have been challenging to monitor outside of medical facilities, providing valuable clinical information to healthcare professionals. This enables early intervention for patients at high risk of preterm birth and helps reduce unnecessary treatments.
In the first clinical study, which began in 2023, we achieved highly promising results. We are now conducting a second clinical study to further accumulate reliable evidence and build a more versatile algorithm. (For more details about this research, please refer to the link below.)
We are committed to saving as many lives as possible and enriching the lives of more women by striving for rapid societal implementation.